(Yicai Global) Jan. 20 -- China's mainland stock markets went even higher this afternoon, as Shenzhen's tech board rose to a three-year high led by the medical sector as China reports mushrooming cases a new coronavirus that originated in the central city of Wuhan.

The ChiNext Price Index, which tracks in Shenzhen-listed growth enterprises, rose 2.57 percent to 1,982.18, a summit unvisited in three years. The Shanghai Composite Index climbed 0.66 percent to 3,095.79, and the Shenzhen Component Index up 1.47 percent to 11,115.88.

More than a dozen pharma firms hit the 10 percent daily upper limit at close, including antibiotic producer Shandong Lukang Pharmaceutical [SHA:600789], virus detection firm Da An Gene [SHE:002030], and antiviral oral-liquid maker Xiangxue Pharmaceutical [SHE:300147], after health authorities in Central China's Wuhan confirmed 136 new coronavirus cases and its third fatality.

Editor: Ben Armour